Paper16368705
Rapamycin alleviates toxicity of different aggregate-prone proteins.
Berger Z and 10 others. Hum Mol Genet, 2006. Cited by 544 papers, by iCite.
Cite this record
ConductScience Library. Rapamycin alleviates toxicity of different aggregate-prone proteins. Papers, record 16368705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16368705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proteins | Major topic |
| Sirolimus | Major topic |
| Animals | |
| Autophagy | |
| COS Cells | |
| Cells, Cultured | |
| Chlorocebus aethiops | |
| Drosophila | |
| Huntington Disease | |
| Mutation | |
| Peptides | |
| Protein Structure, Quaternary | |
| Trinucleotide Repeat Expansion | |
| tau Proteins |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0000872 | Medical Research Council | United Kingdom | PubMed | |
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
Cited by333
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 544 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42640981 | High reelin expression may explain why a subgroup of entorhinal cortex neurons functions as an initial nucleation site of Alzheimer's disease. | PLoS Comput Biol | 2026 | https://conductscience.org/library/papers/42640981 | PubMed |
| 42512450 | Molecular Mechanisms of Neurodegenerative Diseases: Emerging Biomarkers and Therapeutic Targets. | Brain Sci | 2026 | https://conductscience.org/library/papers/42512450 | PubMed |
| 42121856 | Cytoskeletal Imbalance and Axonal Vulnerability in Sporadic PSP-RS: Early Changes in a Human iPSC-Derived Neuronal Model with Altered mTOR Signaling. | Cells | 2026 | https://conductscience.org/library/papers/42121856 | PubMed |
| 41123674 | The connection between autophagy and Alzheimer's disease. | Inflamm Res | 2025 | https://conductscience.org/library/papers/41123674 | PubMed |
| 41121328 | Low-dose rapamycin alleviates clinical symptoms of fatigue and PEM in ME/CFS patients via improvement of autophagy: a pilot study. | J Transl Med | 2025 | https://conductscience.org/library/papers/41121328 | PubMed |
| 40954318 | Mutation-induced filaments of folded proteins are inert and non-toxic in a cellular system. | Mol Syst Biol | 2025 | https://conductscience.org/library/papers/40954318 | PubMed |
| 40818063 | Inhibition of UBE2N promotes the clearance of mutant HTT (huntingtin) in HD knock-in mice. | Autophagy | 2025 | https://conductscience.org/library/papers/40818063 | PubMed |
| 40806649 | Upregulating ANKHD1 in PS19 Mice Reduces Tau Phosphorylation and Mitigates Tau Toxicity-Induced Cognitive Deficits. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806649 | PubMed |
| 40304712 | Inborn errors of canonical autophagy in neurodegenerative diseases. | Hum Mol Genet | 2025 | https://conductscience.org/library/papers/40304712 | PubMed |
| 40299664 | The Role of mTOR in Amyotrophic Lateral Sclerosis. | Biomedicines | 2025 | https://conductscience.org/library/papers/40299664 | PubMed |
| 40292249 | Correlation of autophagy and Alzheimer's disease with special emphasis on the role of phosphodiesterase-4. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40292249 | PubMed |
| 40182757 | Parishin A ameliorates cognitive decline by promoting PS1 autophagy in Alzheimer's disease. | Front Aging Neurosci | 2025 | https://conductscience.org/library/papers/40182757 | PubMed |
| 40109357 | Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration. | J Ophthalmol | 2025 | https://conductscience.org/library/papers/40109357 | PubMed |
| 39174070 | Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol. | BMJ Open | 2024 | https://conductscience.org/library/papers/39174070 | PubMed |
| 38932463 | Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease. | Aging Cell | 2024 | https://conductscience.org/library/papers/38932463 | PubMed |
| 38920658 | CCT and Cullin1 Regulate the TORC1 Pathway to Promote Dendritic Arborization in Health and Disease. | Cells | 2024 | https://conductscience.org/library/papers/38920658 | PubMed |
| 38740758 | Reduction of spermine synthase enhances autophagy to suppress Tau accumulation. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38740758 | PubMed |
| 38704365 | EPB41L4A-AS1 is required to maintain basal autophagy to modulates Aβ clearance. | NPJ Aging | 2024 | https://conductscience.org/library/papers/38704365 | PubMed |
| 38623984 | Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology. | Curr Alzheimer Res | 2024 | https://conductscience.org/library/papers/38623984 | PubMed |
| 38259504 | Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches. | Front Cell Neurosci | 2023 | https://conductscience.org/library/papers/38259504 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16368705
GET https://conductscience.org/api/papers/v1/16368705/cited_by?page=2